サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1127503

世界の予測および発症前テスト市場：考察と予測 (2028年まで)

Global Predictive Presymptomatic Testing Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の予測および発症前テスト市場：考察と予測 (2028年まで)
出版日: 2022年09月22日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、予測および発症前テスト (Predictive Presymptomatic Testing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の予測および発症前テストの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Molecular Testing
    • Cytogenic Testing
    • Biochemical Testing
  • 市場：アプリケーション別
    • 世界の予測および発症前テストの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Breast and Ovarian Cancer
    • Colorectal Cancer
    • Alzheimer's Disease
    • Multiple Endocrine Neoplasia Type
    • Haemochromatosis
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の予測および発症前テストの市場展望 (2017-2028)
  • 予測および発症前テストの市場成長トレンド：地域別
    • 予測および発症前テスト 市場規模：地域別: 2017 VS 2021 VS 2028
    • 予測および発症前テストの市場規模実績：地域別 (2017-2022)
    • 予測および発症前テストの市場規模予測：地域別 (2023-2028)
  • 予測および発症前テスト 市場動向
    • 予測および発症前テスト 業界動向
    • 予測および発症前テスト 市場の促進要因
    • 予測および発症前テスト 市場の課題
    • 予測および発症前テスト 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の予測および発症前テストの上位企業：収益別
    • 世界の予測および発症前テストの上位企業：収益別 (2017-2022)
    • 世界の予測および発症前テストの収益シェア：企業別 (2017-2022)
  • 世界の予測および発症前テストの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：予測および発症前テストの収益
  • 世界の予測および発症前テスト 市場集中度
    • 世界の予測および発症前テスト 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 予測および発症前テストの収益 2021
  • 予測および発症前テストの主要企業の本社および事業エリア
  • 主要企業 予測および発症前テストの製品ソリューションおよびサービス
  • 市場参入時期： 予測および発症前テスト 市場
  • M&A, 拡張計画

第4章 予測および発症前テスト 内訳データ：タイプ別

  • 世界の予測および発症前テストの市場規模実績：タイプ別 (2017-2022)
  • 世界の予測および発症前テストの市場規模予測：タイプ別 (2023-2028)

第5章 予測および発症前テスト 内訳データ：アプリケーション別

  • 世界の予測および発症前テストの市場規模実績：アプリケーション別 (2017-2022)
  • 世界の予測および発症前テストの市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の予測および発症前テスト 市場規模 (2017-2028)
  • 北米の予測および発症前テスト 市場規模：タイプ別
    • 北米の予測および発症前テスト 市場規模：タイプ別 (2017-2022)
    • 北米の予測および発症前テスト 市場規模：タイプ別 (2023-2028)
    • 北米の予測および発症前テストの市場シェア：タイプ別 (2017-2028)
  • 北米の予測および発症前テスト 市場規模：アプリケーション別
    • 北米の予測および発症前テスト 市場規模：アプリケーション別 (2017-2022)
    • 北米の予測および発症前テスト 市場規模：アプリケーション別 (2023-2028)
    • 北米の予測および発症前テストの市場シェア：アプリケーション別 (2017-2028)
  • 北米の予測および発症前テスト 市場規模：国別
    • 北米の予測および発症前テスト 市場規模：国別 (2017-2022)
    • 北米の予測および発症前テスト 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の予測および発症前テスト 市場規模 (2017-2028)
  • 欧州の予測および発症前テスト 市場規模：タイプ別
    • 欧州の予測および発症前テスト 市場規模：タイプ別 (2017-2022)
    • 欧州の予測および発症前テスト 市場規模：タイプ別 (2023-2028)
    • 欧州の予測および発症前テストの市場シェア：タイプ別 (2017-2028)
  • 欧州の予測および発症前テスト 市場規模：アプリケーション別
    • 欧州の予測および発症前テスト 市場規模：アプリケーション別 (2017-2022)
    • 欧州の予測および発症前テスト 市場規模：アプリケーション別 (2023-2028)
    • 欧州の予測および発症前テストの市場シェア：アプリケーション別 (2017-2028)
  • 欧州の予測および発症前テスト 市場規模：国別
    • 欧州の予測および発症前テスト 市場規模：国別 (2017-2022)
    • 欧州の予測および発症前テスト 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 予測および発症前テスト 市場規模 (2017-2028)
  • アジア太平洋地域 予測および発症前テスト 市場規模：タイプ別
    • アジア太平洋地域 予測および発症前テスト 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 予測および発症前テスト 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 予測および発症前テストの市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 予測および発症前テスト 市場規模：アプリケーション別
    • アジア太平洋地域 予測および発症前テスト 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 予測および発症前テスト 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 予測および発症前テストの市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 予測および発症前テスト 市場規模：地域別
    • アジア太平洋地域 予測および発症前テスト 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 予測および発症前テスト 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの予測および発症前テスト 市場規模 (2017-2028)
  • ラテンアメリカの予測および発症前テスト 市場規模：タイプ別
    • ラテンアメリカの予測および発症前テスト 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの予測および発症前テスト 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの予測および発症前テストの市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの予測および発症前テスト 市場規模：アプリケーション別
    • ラテンアメリカの予測および発症前テスト 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの予測および発症前テスト 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの予測および発症前テストの市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの予測および発症前テスト 市場規模：国別
    • ラテンアメリカの予測および発症前テスト 市場規模：国別 (2017-2022)
    • ラテンアメリカの予測および発症前テスト 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの予測および発症前テスト 市場規模 (2017-2028)
  • 中東・アフリカの予測および発症前テスト 市場規模：タイプ別
    • 中東・アフリカの予測および発症前テスト 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの予測および発症前テスト 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの予測および発症前テストの市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの予測および発症前テスト 市場規模：アプリケーション別
    • 中東・アフリカの予測および発症前テスト 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの予測および発症前テスト 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの予測および発症前テストの市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの予測および発症前テスト 市場規模：国別
    • 中東・アフリカの予測および発症前テスト 市場規模：国別 (2017-2022)
    • 中東・アフリカの予測および発症前テスト 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • 23andMe, Inc.
  • Abbott Laboratories
  • Bayer HealthCare AG
  • Biocartis SA
  • BioHelix Corporation
  • bioMerieux S.A.
  • Celera Corporation (Quest Diagnostics)
  • Cepheid (Danaher)
  • Daan Diagnostics Ltd.
  • EKF Diagnostics Holdings plc

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Predictive Presymptomatic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Molecular Testing
  • Table 3. Key Players of Cytogenic Testing
  • Table 4. Key Players of Biochemical Testing
  • Table 5. Global Predictive Presymptomatic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Predictive Presymptomatic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Predictive Presymptomatic Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Predictive Presymptomatic Testing Market Share by Region (2017-2022)
  • Table 9. Global Predictive Presymptomatic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Predictive Presymptomatic Testing Market Share by Region (2023-2028)
  • Table 11. Predictive Presymptomatic Testing Market Trends
  • Table 12. Predictive Presymptomatic Testing Market Drivers
  • Table 13. Predictive Presymptomatic Testing Market Challenges
  • Table 14. Predictive Presymptomatic Testing Market Restraints
  • Table 15. Global Predictive Presymptomatic Testing Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Predictive Presymptomatic Testing Revenue Share by Players (2017-2022)
  • Table 17. Global Top Predictive Presymptomatic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2021)
  • Table 18. Ranking of Global Top Predictive Presymptomatic Testing Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Predictive Presymptomatic Testing Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Predictive Presymptomatic Testing Product Solution and Service
  • Table 22. Date of Enter into Predictive Presymptomatic Testing Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2017-2022)
  • Table 26. Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Predictive Presymptomatic Testing Revenue Market Share by Type (2023-2028)
  • Table 28. Global Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Predictive Presymptomatic Testing Revenue Share by Application (2017-2022)
  • Table 30. Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Predictive Presymptomatic Testing Revenue Share by Application (2023-2028)
  • Table 32. North America Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Predictive Presymptomatic Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Predictive Presymptomatic Testing Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Predictive Presymptomatic Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Predictive Presymptomatic Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Predictive Presymptomatic Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Predictive Presymptomatic Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Predictive Presymptomatic Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Predictive Presymptomatic Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. 23andMe, Inc. Company Details
  • Table 63. 23andMe, Inc. Business Overview
  • Table 64. 23andMe, Inc. Predictive Presymptomatic Testing Product
  • Table 65. 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 66. 23andMe, Inc. Recent Developments
  • Table 67. Abbott Laboratories Company Details
  • Table 68. Abbott Laboratories Business Overview
  • Table 69. Abbott Laboratories Predictive Presymptomatic Testing Product
  • Table 70. Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 71. Abbott Laboratories Recent Developments
  • Table 72. Bayer HealthCare AG Company Details
  • Table 73. Bayer HealthCare AG Business Overview
  • Table 74. Bayer HealthCare AG Predictive Presymptomatic Testing Product
  • Table 75. Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 76. Bayer HealthCare AG Recent Developments
  • Table 77. Biocartis SA Company Details
  • Table 78. Biocartis SA Business Overview
  • Table 79. Biocartis SA Predictive Presymptomatic Testing Product
  • Table 80. Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 81. Biocartis SA Recent Developments
  • Table 82. BioHelix Corporation Company Details
  • Table 83. BioHelix Corporation Business Overview
  • Table 84. BioHelix Corporation Predictive Presymptomatic Testing Product
  • Table 85. BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 86. BioHelix Corporation Recent Developments
  • Table 87. bioMerieux S.A. Company Details
  • Table 88. bioMerieux S.A. Business Overview
  • Table 89. bioMerieux S.A. Predictive Presymptomatic Testing Product
  • Table 90. bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 91. bioMerieux S.A. Recent Developments
  • Table 92. Celera Corporation (Quest Diagnostics) Company Details
  • Table 93. Celera Corporation (Quest Diagnostics) Business Overview
  • Table 94. Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Product
  • Table 95. Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 96. Celera Corporation (Quest Diagnostics) Recent Developments
  • Table 97. Cepheid (Danaher) Company Details
  • Table 98. Cepheid (Danaher) Business Overview
  • Table 99. Cepheid (Danaher) Predictive Presymptomatic Testing Product
  • Table 100. Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 101. Cepheid (Danaher) Recent Developments
  • Table 102. Daan Diagnostics Ltd. Company Details
  • Table 103. Daan Diagnostics Ltd. Business Overview
  • Table 104. Daan Diagnostics Ltd. Predictive Presymptomatic Testing Product
  • Table 105. Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 106. Daan Diagnostics Ltd. Recent Developments
  • Table 107. EKF Diagnostics Holdings plc Company Details
  • Table 108. EKF Diagnostics Holdings plc Business Overview
  • Table 109. EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Product
  • Table 110. EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2017-2022) & (US$ Million)
  • Table 111. EKF Diagnostics Holdings plc Recent Developments
  • Table 112. Research Programs/Design for This Report
  • Table 113. Key Data Information from Secondary Sources
  • Table 114. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Predictive Presymptomatic Testing Market Share by Type: 2021 VS 2028
  • Figure 2. Molecular Testing Features
  • Figure 3. Cytogenic Testing Features
  • Figure 4. Biochemical Testing Features
  • Figure 5. Global Predictive Presymptomatic Testing Market Share by Application: 2021 VS 2028
  • Figure 6. Breast and Ovarian Cancer Case Studies
  • Figure 7. Colorectal Cancer Case Studies
  • Figure 8. Alzheimer's Disease Case Studies
  • Figure 9. Multiple Endocrine Neoplasia Type 2 Case Studies
  • Figure 10. Haemochromatosis Case Studies
  • Figure 11. Predictive Presymptomatic Testing Report Years Considered
  • Figure 12. Global Predictive Presymptomatic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Predictive Presymptomatic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Predictive Presymptomatic Testing Market Share by Region: 2021 VS 2028
  • Figure 15. Global Predictive Presymptomatic Testing Market Share by Players in 2021
  • Figure 16. Global Top Predictive Presymptomatic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Predictive Presymptomatic Testing as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Predictive Presymptomatic Testing Revenue in 2021
  • Figure 18. North America Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 22. United States Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 28. Germany Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Predictive Presymptomatic Testing Market Size Share by Region (2017-2028)
  • Figure 38. China Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 44. Latin America Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Predictive Presymptomatic Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Predictive Presymptomatic Testing Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Predictive Presymptomatic Testing Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Predictive Presymptomatic Testing Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Predictive Presymptomatic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. 23andMe, Inc. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 58. Abbott Laboratories Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 59. Bayer HealthCare AG Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 60. Biocartis SA Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 61. BioHelix Corporation Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 62. bioMerieux S.A. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 63. Celera Corporation (Quest Diagnostics) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 64. Cepheid (Danaher) Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 65. Daan Diagnostics Ltd. Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 66. EKF Diagnostics Holdings plc Revenue Growth Rate in Predictive Presymptomatic Testing Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
目次

This research report focuses on the Predictive Presymptomatic Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Molecular Testing
    • 1.2.3 Cytogenic Testing
    • 1.2.4 Biochemical Testing
  • 1.3 Market by Application
    • 1.3.1 Global Predictive Presymptomatic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Breast and Ovarian Cancer
    • 1.3.3 Colorectal Cancer
    • 1.3.4 Alzheimer's Disease
    • 1.3.5 Multiple Endocrine Neoplasia Type 2
    • 1.3.6 Haemochromatosis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Predictive Presymptomatic Testing Market Perspective (2017-2028)
  • 2.2 Predictive Presymptomatic Testing Growth Trends by Region
    • 2.2.1 Predictive Presymptomatic Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Predictive Presymptomatic Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 Predictive Presymptomatic Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Predictive Presymptomatic Testing Market Dynamics
    • 2.3.1 Predictive Presymptomatic Testing Industry Trends
    • 2.3.2 Predictive Presymptomatic Testing Market Drivers
    • 2.3.3 Predictive Presymptomatic Testing Market Challenges
    • 2.3.4 Predictive Presymptomatic Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Predictive Presymptomatic Testing Players by Revenue
    • 3.1.1 Global Top Predictive Presymptomatic Testing Players by Revenue (2017-2022)
    • 3.1.2 Global Predictive Presymptomatic Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Predictive Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Predictive Presymptomatic Testing Revenue
  • 3.4 Global Predictive Presymptomatic Testing Market Concentration Ratio
    • 3.4.1 Global Predictive Presymptomatic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Predictive Presymptomatic Testing Revenue in 2021
  • 3.5 Predictive Presymptomatic Testing Key Players Head office and Area Served
  • 3.6 Key Players Predictive Presymptomatic Testing Product Solution and Service
  • 3.7 Date of Enter into Predictive Presymptomatic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Predictive Presymptomatic Testing Breakdown Data by Type

  • 4.1 Global Predictive Presymptomatic Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Type (2023-2028)

5 Predictive Presymptomatic Testing Breakdown Data by Application

  • 5.1 Global Predictive Presymptomatic Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global Predictive Presymptomatic Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Predictive Presymptomatic Testing Market Size (2017-2028)
  • 6.2 North America Predictive Presymptomatic Testing Market Size by Type
    • 6.2.1 North America Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 6.2.2 North America Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 6.2.3 North America Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 6.3 North America Predictive Presymptomatic Testing Market Size by Application
    • 6.3.1 North America Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 6.3.2 North America Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 6.3.3 North America Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 6.4 North America Predictive Presymptomatic Testing Market Size by Country
    • 6.4.1 North America Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 6.4.2 North America Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Predictive Presymptomatic Testing Market Size (2017-2028)
  • 7.2 Europe Predictive Presymptomatic Testing Market Size by Type
    • 7.2.1 Europe Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 7.3 Europe Predictive Presymptomatic Testing Market Size by Application
    • 7.3.1 Europe Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 7.4 Europe Predictive Presymptomatic Testing Market Size by Country
    • 7.4.1 Europe Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Predictive Presymptomatic Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type
    • 8.2.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application
    • 8.3.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region
    • 8.4.1 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Predictive Presymptomatic Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Predictive Presymptomatic Testing Market Size (2017-2028)
  • 9.2 Latin America Predictive Presymptomatic Testing Market Size by Type
    • 9.2.1 Latin America Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Predictive Presymptomatic Testing Market Size by Application
    • 9.3.1 Latin America Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Predictive Presymptomatic Testing Market Size by Country
    • 9.4.1 Latin America Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Predictive Presymptomatic Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type
    • 10.2.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Predictive Presymptomatic Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application
    • 10.3.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Predictive Presymptomatic Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country
    • 10.4.1 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Predictive Presymptomatic Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 23andMe, Inc.
    • 11.1.1 23andMe, Inc. Company Details
    • 11.1.2 23andMe, Inc. Business Overview
    • 11.1.3 23andMe, Inc. Predictive Presymptomatic Testing Introduction
    • 11.1.4 23andMe, Inc. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.1.5 23andMe, Inc. Recent Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Predictive Presymptomatic Testing Introduction
    • 11.2.4 Abbott Laboratories Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.2.5 Abbott Laboratories Recent Developments
  • 11.3 Bayer HealthCare AG
    • 11.3.1 Bayer HealthCare AG Company Details
    • 11.3.2 Bayer HealthCare AG Business Overview
    • 11.3.3 Bayer HealthCare AG Predictive Presymptomatic Testing Introduction
    • 11.3.4 Bayer HealthCare AG Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.3.5 Bayer HealthCare AG Recent Developments
  • 11.4 Biocartis SA
    • 11.4.1 Biocartis SA Company Details
    • 11.4.2 Biocartis SA Business Overview
    • 11.4.3 Biocartis SA Predictive Presymptomatic Testing Introduction
    • 11.4.4 Biocartis SA Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.4.5 Biocartis SA Recent Developments
  • 11.5 BioHelix Corporation
    • 11.5.1 BioHelix Corporation Company Details
    • 11.5.2 BioHelix Corporation Business Overview
    • 11.5.3 BioHelix Corporation Predictive Presymptomatic Testing Introduction
    • 11.5.4 BioHelix Corporation Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.5.5 BioHelix Corporation Recent Developments
  • 11.6 bioMerieux S.A.
    • 11.6.1 bioMerieux S.A. Company Details
    • 11.6.2 bioMerieux S.A. Business Overview
    • 11.6.3 bioMerieux S.A. Predictive Presymptomatic Testing Introduction
    • 11.6.4 bioMerieux S.A. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.6.5 bioMerieux S.A. Recent Developments
  • 11.7 Celera Corporation (Quest Diagnostics)
    • 11.7.1 Celera Corporation (Quest Diagnostics) Company Details
    • 11.7.2 Celera Corporation (Quest Diagnostics) Business Overview
    • 11.7.3 Celera Corporation (Quest Diagnostics) Predictive Presymptomatic Testing Introduction
    • 11.7.4 Celera Corporation (Quest Diagnostics) Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.7.5 Celera Corporation (Quest Diagnostics) Recent Developments
  • 11.8 Cepheid (Danaher)
    • 11.8.1 Cepheid (Danaher) Company Details
    • 11.8.2 Cepheid (Danaher) Business Overview
    • 11.8.3 Cepheid (Danaher) Predictive Presymptomatic Testing Introduction
    • 11.8.4 Cepheid (Danaher) Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.8.5 Cepheid (Danaher) Recent Developments
  • 11.9 Daan Diagnostics Ltd.
    • 11.9.1 Daan Diagnostics Ltd. Company Details
    • 11.9.2 Daan Diagnostics Ltd. Business Overview
    • 11.9.3 Daan Diagnostics Ltd. Predictive Presymptomatic Testing Introduction
    • 11.9.4 Daan Diagnostics Ltd. Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.9.5 Daan Diagnostics Ltd. Recent Developments
  • 11.10 EKF Diagnostics Holdings plc
    • 11.10.1 EKF Diagnostics Holdings plc Company Details
    • 11.10.2 EKF Diagnostics Holdings plc Business Overview
    • 11.10.3 EKF Diagnostics Holdings plc Predictive Presymptomatic Testing Introduction
    • 11.10.4 EKF Diagnostics Holdings plc Revenue in Predictive Presymptomatic Testing Business (2017-2022)
    • 11.10.5 EKF Diagnostics Holdings plc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer